Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
656 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00521482 | Temozolomide vs. Temozolomide and Thalidomide Treatment in Recurrent Glioblastoma | unknown | Phase 2 | 40 | University of ZurichOTHER | 1 | Aug 28, 2007 | clinicaltrials |
| NCT00490360 | Neoadjuvant Chemotherapy for Resectable Cancer of the Pancreatic Head | completed | Phase 2 | 2,007 | University of ZurichOTHER | 1 | Jun 22, 2007 | clinicaltrials |
| NCT00272740 |
| SAKK - a Trial to Evaluate Antitumor Efficacy of Faslodex® After Aromatase Inhibitor Failure in Advanced Breast Cancer |
| completed |
| Phase 2 |
| 93 |
| AstraZenecaINDUSTRY |
| 2 |
| Feb 9, 2007 |
| clinicaltrials |
| NCT00306553 | Safety and Immunogenicity of a Melan-A VLP Vaccine in Advanced Stage Melanoma Patients | completed | Phase 2 | — | Cytos Biotechnology AGINDUSTRY | 1 | Sep 19, 2006 | clinicaltrials |
| NCT00138086 | Yttrium-90 Ibritumomab Tiuxetan (Zevalin) With BEAM in Relapsed Low Grade B-Cell Lymphoma | completed | Phase 2 | 75 | Lymphoma Study AssociationOTHER | 3 | Sep 8, 2006 | clinicaltrials |
| NCT00088270 | A Study of OSI-7904L Versus 5-FU/LV as Treatment in Patients With Biliary Tract Cancer | completed | Phase 2 | 58 | OSI PharmaceuticalsINDUSTRY | 6 | Feb 22, 2006 | clinicaltrials |
Data updated 22 days agoSource updated unknownsource: clinicaltrials